Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An Elderly Man with Fatigue, Dyspnea, and Kidney Failure.

× No keyword cloud information.

15 in total

1. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.

Authors: H K Choi; P A Merkel; A M Walker; J L Niles
Journal: Arthritis Rheum Date: 2000-02

2. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors: John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal: N Engl J Med Date: 2010-07-15 Impact factor: 91.245

3. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors: Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal: N Engl J Med Date: 2010-07-15 Impact factor: 91.245

4. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

Authors: Lorraine Harper; Matthew D Morgan; Michael Walsh; Peter Hoglund; Kerstin Westman; Oliver Flossmann; Vladimir Tesar; Phillipe Vanhille; Kirsten de Groot; Raashid Luqmani; Luis Felipe Flores-Suarez; Richard Watts; Charles Pusey; Annette Bruchfeld; Niels Rasmussen; Daniel Blockmans; Caroline O Savage; David Jayne
Journal: Ann Rheum Dis Date: 2011-11-29 Impact factor: 19.103

Review 5. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient.

Authors: Jai Radhakrishnan; Daniel C Cattran
Journal: Kidney Int Date: 2012-08-15 Impact factor: 10.612

An Elderly Man with Fatigue, Dyspnea, and Kidney Failure.

1. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.

2. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

3. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

4. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.

Review 5. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient.

6. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.

Review 7. Rituximab-induced vasculitis: A case report and review of the medical published work.

Review 8. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis.

9. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.

Review 10. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.

1. Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis.